About Aristo Bio-Tech And Lifescience Limited
Data last updated: 25 December 2025
Aristo Bio-Tech And Lifescience Limited is a public limited company based in Vadodara, Gujarat, India. It specialises in chemical products, a part of the broader chemicals sector. Incorporated on 17 March 2005, the company has been in operation for over 21 years.
Registered with ROC Ahmedabad under CIN U01100GJ2005PLC127397. Listed.
Capital: an authorised share capital of ₹8 Cr and a paid-up capital of ₹6.81 Cr. Formerly known as Aristo Bio-Tech and Lifescience Private Limited. It is led by directors including Raghavender Mateti and Narendra Singh Barhat.
Last AGM: 08 September 2025. Financial statements filed for year ended 31 March 2025. Office: E – 24 25 26 G.I.D.C. Manjusar Ta. Savli, Vadodara, Gujarat, India – 391775.
As per the financials filed for FY 2025, the company reported a revenue of ₹318.55 Cr, a growth of 30% compared to the previous year.
The company has a workforce of approximately 53 employees as per the latest available data.
The company is associated with 1 brand - Aristo Biotech. As per MCA filings, the company has open charges of ₹70.71 Cr and satisfied charges of ₹9.61 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aristobiotech.com.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media
-
Registered AddressE – 24 25 26 G.I.D.C. Manjusar Ta. Savli, Vadodara, Gujarat, India – 391775
-
IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Aristo Bio-Tech And Lifescience Limited
Aristo Bio-Tech And Lifescience Limited has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L01100GJ2005PLC127397, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L01100GJ2005PLC127397 | Current |
| U01100GJ2005PLC127397 | Previous |
| U01100MH2005PTC152037 | Previous |
| U01100MH2005PLC152037 | Previous |
Associated Brands with Aristo Bio-Tech And Lifescience Limited
Aristo Bio-Tech And Lifescience Limited operates one associated brand: Aristo Biotech. These brands represent Aristo Bio-Tech And Lifescience Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Audio news content is provided to radio stations for broadcast. | aristobiotech.com |
Competitors & Alternatives of Aristo Bio-Tech And Lifescience Limited
Brands and companies operating in the same space as Aristo Bio-Tech And Lifescience Limited include Diversey, Inventys, Modern Synthesis and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Diversey
|
Water treatment and hygiene solutions are provided for various industries. | Fort Mill, United States, United States | 1998 |
Inventys
|
Actives, advanced intermediates, and specialty chemicals are custom manufactured. | Mumbai, India, India | 2005 |
Modern Synthesis
|
Biomaterials are developed via microbial fermentation for diverse applications. | London, United Kingdom, United Kingdom | 2019 |
Reliance Steel & Aluminum
|
Contract manufacturer of chemical, automotive, aircraft, and other products | Los Angeles, United States, United States | 1939 |
Shogun Organics
|
Contract manufacturer of chemicals used in household insecticide products | Mumbai, India, India | 2002 |
Cupid
|
Contract manufacturer of male & female condoms | Nashik, India, India | 1993 |
FAZE THREE LIMITED
|
Home furnishings and automobile textiles are contract-manufactured. | Mumbai, India, India | 1985 |
VINI International
|
Beauty care products are manufactured through contract services. | Dubai, United Arab Emirates, United Arab Emirates | 2010 |
Byborre
|
Online B2B platform offering e-commerce software suite for fashion businesses | Amsterdam, Netherlands, Netherlands | 2010 |
Business Activity of Aristo Bio-Tech And Lifescience Limited
Aristo Bio-Tech And Lifescience Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Board of Directors of Aristo Bio-Tech And Lifescience Limited
Aristo Bio-Tech And Lifescience Limited is currently managed by 7 directors, with 9 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raghavender Mateti | Director | 10 Sep 2018 | 7 Years 10 Months | Current |
|
Narendra Singh Barhat
Also directs:
Barhatji Mewar (Paaner) Foundation, Indus Finechem Llp
|
Managing Director | 17 Mar 2005 | 21 Years 3 Months | Current |
| Laxman Singh Rathore | Director | 20 Mar 2022 | 4 Years 3 Months | Current |
|
Rashmi Kamlesh Otavani
Also directs:
Madhusudan Masala Limited, United Polyfab Gujarat Limited, Cryogenic Ogs Limited and 2 more
|
Director | 20 Mar 2022 | 4 Years 3 Months | Current |
|
Ketankumar Harkantbhai Joshi
Also directs:
Indus Finechem Llp
|
Whole-Time Director | 27 Aug 2018 | 7 Years 10 Months | Current |
|
Kusum Narendra Singh Barhat
Also directs:
Barhatji Mewar (Paaner) Foundation
|
Director | 17 Mar 2005 | 21 Years 3 Months | Current |
Financials of Aristo Bio-Tech And Lifescience Limited FY 2025 filings available
Aristo Bio-Tech And Lifescience Limited reported revenue of ₹318.55 Cr (up 30% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Aristo Bio-Tech And Lifescience Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Aug 2025 | Standard Chartered Bank | ₹1 Cr | Open |
| 18 Feb 2025 | Sidbi | ₹2.74 Cr | Open |
| 20 Sep 2022 | Others | ₹1.36 Cr | Open |
| 24 Nov 2021 | Others | ₹3.18 Cr | Open |
| 02 Dec 2020 | Others | ₹1.73 Cr | Open |
Total charge records: 11 View all charges
Employees and EPFO Compliance at Aristo Bio-Tech And Lifescience Limited
View historical data on people associated with Aristo Bio-Tech And Lifescience Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Aristo Bio-Tech And Lifescience Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Aristo Bio-Tech And Lifescience Limited
GSTIN & GST Filing Data of Aristo Bio-Tech And Lifescience Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Aristo Bio-Tech And Lifescience Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Aristo Bio-Tech And Lifescience Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Aristo Bio-Tech And Lifescience Limited
MSME Payment Delays by Aristo Bio-Tech And Lifescience Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Aristo Bio-Tech And Lifescience Limited
Subsidiaries & Group Companies of Aristo Bio-Tech And Lifescience Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Aristo Bio-Tech And Lifescience Limited with ownership details.
MCA Filings & Documents of Aristo Bio-Tech And Lifescience Limited
MCA Filings & Documents of Aristo Bio-Tech And Lifescience Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Aristo Bio-Tech And Lifescience Limited
Frequently Asked Questions about Aristo Bio-Tech And Lifescience Limited
Aristo Bio-Tech And Lifescience Limited is an active public limited company in the chemicals sector based in Vadodara, Gujarat, India. It was incorporated on 17 March 2005 (21+ years old) and is registered under CIN L01100GJ2005PLC127397. The company has 53 employees.
Aristo Bio-Tech And Lifescience Limited reported revenue of ₹318.55 Cr for FY 2025 (up 30.00% YoY).
The current directors of Aristo Bio-Tech And Lifescience Limited are:
The primary industry of Aristo Bio-Tech And Lifescience Limited is chemicals. The company specifically operates in chemical products. The company is currently active in this sector.
Yes, Aristo Bio-Tech And Lifescience Limited is a listed company.
Aristo Bio-Tech And Lifescience Limited can be reached at the registered office: E – 24 25 26 G.I.D.C. Manjusar Ta. Savli, Vadodara, Gujarat, India – 391775, or through the website aristobiotech.com.